How does fludrocortisone (mineralocorticoid) work in the treatment of primary adrenal insufficiency (Addison disease)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How Fludrocortisone Works in Addison Disease

Fludrocortisone is a synthetic mineralocorticoid that replaces the deficient aldosterone in primary adrenal insufficiency by acting on the distal renal tubules to enhance sodium reabsorption, increase potassium and hydrogen ion excretion, and maintain blood pressure and electrolyte homeostasis 1, 2.

Mechanism of Action

Fludrocortisone mimics the physiological action of aldosterone, the naturally occurring mineralocorticoid that is deficient in Addison disease. The drug works through the following specific mechanisms 2:

  • Acts on distal renal tubules to enhance reabsorption of sodium ions from tubular fluid back into plasma
  • Increases urinary excretion of both potassium and hydrogen ions
  • Raises blood pressure as a consequence of these electrolyte effects and volume expansion
  • Has a plasma half-life of 3.5 hours but a biological half-life of 18-36 hours, allowing once-daily dosing

The mineralocorticoid effects of fludrocortisone are considerably heightened and prolonged compared to hydrocortisone, making it the preferred agent for mineralocorticoid replacement 2.

Clinical Rationale for Use

All patients with confirmed aldosterone deficiency in primary adrenal insufficiency require mineralocorticoid replacement 1. This is critical because mineralocorticoids are vital for maintaining water and electrolyte homeostasis and blood pressure 1. Without adequate replacement, patients develop:

  • Salt craving
  • Postural hypotension
  • Weakness
  • Hyperkalemia
  • Hyponatremia

Dosing Strategy

The standard dose is 0.05-0.2 mg daily, typically taken once in the morning 1, 3, 2. The morning timing follows the rationale that aldosterone levels are highest at this time due to circadian rhythm similar to cortisol 1.

Important dosing considerations:

  • Children require higher doses than adults (per body surface area) due to lower mineralocorticoid sensitivity 1
  • Dose adjustments of 50-100% may be needed in hot climates or conditions causing excessive sweating 1
  • Patients on prednisolone require more fludrocortisone than those on hydrocortisone because prednisolone has less mineralocorticoid activity 1, 3
  • Dexamethasone has no mineralocorticoid activity, so patients on dexamethasone require full mineralocorticoid replacement 1, 3

Monitoring Parameters

Monitoring relies primarily on clinical assessment rather than laboratory values alone 1. The key parameters are:

Clinical indicators:

  • Absence of salt craving
  • No postural hypotension (check sitting and standing blood pressure)
  • Absence of peripheral edema
  • General well-being

Laboratory markers:

  • Electrolytes within normal range (sodium, potassium)
  • Plasma renin activity in the upper reference range is the most useful marker for correct dosing 1, 4

A common pitfall is that current replacement regimens may be associated with mild hypovolemia, so careful attention to these parameters is essential 5.

Dose Adjustment Algorithm

If hypertension develops:

  1. First, reduce fludrocortisone dose 1
  2. If blood pressure remains uncontrolled, initiate antihypertensive treatment while continuing fludrocortisone 1
  3. Consider that over-replacement with glucocorticoids can also cause hypertension, so evaluate both medications 1

If signs of under-replacement appear (salt craving, postural hypotension, hyperkalemia):

  • Increase fludrocortisone dose
  • Advise patients not to restrict salt intake 1

Drug Interactions to Avoid

  • Licorice and grapefruit juice potentiate the mineralocorticoid effect of hydrocortisone and should be avoided 1
  • Phenytoin increases fludrocortisone metabolism, requiring higher replacement doses 1

Relationship with Glucocorticoid Therapy

Fludrocortisone prescription appears to be independent of glucocorticoid replacement dose in clinical practice 6. However, it's important to recognize that hydrocortisone itself has potent mineralocorticoid activity, which can contribute to overall mineralocorticoid effect 3, 2. This is why the combined effect must be considered when adjusting either medication.

Related Questions

What is the recommended dosing regimen for fludrocortisone in adults and children with primary adrenal insufficiency, including starting doses and titration guidelines?
What is the recommended dosing, titration, and monitoring for fludrocortisone acetate 0.05 mg oral tablet in patients needing mineralocorticoid replacement?
What are the indications, dosing regimen, and monitoring recommendations for fludrocortisone therapy?
Is fludrocortisone a mineralocorticoid rather than a glucocorticoid?
How should hydrocortisone be used for glucocorticoid replacement in adult patients with adrenal insufficiency, including initial dosing, stress dosing, surgical dosing, and the need for fludrocortisone mineralocorticoid replacement?
What rise in serum creatinine warrants discontinuation of intravenous loop diuretics (e.g., >0.5 mg/dL or ~30% increase, or >0.3 mg/dL if baseline >2 mg/dL)?
What is the recommended postoperative follow-up and management for a patient after femoropopliteal bypass and embolectomy?
How should I evaluate and manage a 67-year-old man with mild normocytic, normochromic anemia (hemoglobin 12.8 g/dL, hematocrit 39.5 %) and otherwise normal complete blood count results?
What is the appropriate medical management for a dog bite and a tick bite?
In an adult with known thyroid carcinoma who develops a new facial rash, what are the possible etiologies and recommended evaluation and management?
What anxiety medication should be used for four weeks after bariatric surgery in a patient who cannot swallow extended‑release tablets and is currently taking desvenlafaxine 50 mg extended‑release?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.